naciri
mancassola
r
p
peeter
je
effect
halofuginon
lactat
experiment
cryptosporidium
parvum
infect
calv
vet
parasitol
chemoprophylact
effect
halofuginon
lactat
test
calf
experiment
cryptosporidiosi
twenti
calv
divid
four
group
oral
inocul
oocyst
cryptosporidium
parvum
infect
control
group
unmed
wherea
three
group
medic
drug
kg
day
respect
day
day
postinocul
inocul
day
calv
weigh
twice
weekli
diseas
develop
drug
efficaci
assess
daili
consist
fece
shed
oocyst
mortal
experiment
c
parvum
infect
caus
sever
clinic
diseas
profus
wateri
diarrhea
high
oocyst
shed
mortal
unmed
group
result
clearli
demonstr
efficaci
halofuginon
lactat
reduc
sever
clinic
cryptosporidiosi
efficaci
dosedepend
lowest
dose
g
kgt
day
abl
prevent
clinic
diseas
mortal
clinic
sign
observ
kg
day
dose
anim
shed
oocyst
drug
withdraw
shed
delay
higher
dose
drug
administ
delay
shed
effect
growth
anim
protozoan
cryptosporidium
parvum
import
coccidi
parasit
intestin
respiratori
tract
sever
speci
vertebr
includ
human
although
concurr
infect
enteropathogen
escherichia
coli
rotavirus
coronavirus
occur
neonat
calv
c
parvurn
alon
may
caus
sever
diarrhea
weight
loss
dehydr
mortal
antimicrobi
drug
includ
coccidiostat
antiprotozo
drug
moon
et
al
b
tzipori
et
al
angu
et
al
kim
lindsay
et
al
naciri
regh
hancock
villacorta
et
al
broadspectrum
antibiot
sloper
et
al
sulphamid
nagi
pohlenz
fischer
gunther
gunther
naciri
et
al
even
anthelminth
stemmermann
et
al
sloper
et
al
shown
inact
cryptosporidium
human
anim
moment
treatment
lasalocidsodium
mg
kg
bodi
weight
day
day
experiment
natur
infect
calv
gsbel
halofuginon
lactat
kg
dayfor
day
experiment
infect
lamb
naciri
shown
effect
halofuginon
lactat
anticoccidi
drug
initi
use
treatment
bovin
theileriosi
villacorta
et
al
establish
halofuginon
lactat
dosag
close
toxic
concentr
test
lower
concentr
tri
avoid
toxic
effect
guarante
secur
five
drug
effect
practic
dose
day
consecut
day
neonat
calv
natur
infect
c
parvum
aim
studi
determin
chemoprophylact
effect
halofuginon
lactat
daili
dose
kg
day
consecut
day
experiment
infect
neonat
calv
twenti
male
femal
colostrumf
calv
mix
holsteinfriesian
breed
obtain
tradit
calf
breeder
separ
dam
day
age
individu
fed
commerci
milk
replac
twice
day
milk
replac
contain
antibiot
vitamin
nutrit
supplement
anim
vaccin
bovin
pathogen
deliv
calv
divid
four
experiment
group
five
anim
rear
two
room
ten
calv
per
room
strict
hygien
measur
taken
includ
filter
air
avoid
extran
infect
anim
four
group
calv
inocul
sporul
oocyst
c
parvum
h
old
control
group
remain
unmed
wherea
three
group
medic
halofuginon
lactat
kg
day
l
respect
day
day
postinocul
pi
strain
c
parvum
use
free
microbi
viral
pathogen
agent
isol
child
arnaudbattandi
et
al
serial
propag
year
lamb
calv
without
exposur
anticoccidi
treatment
fecal
sampl
contain
cryptosporidium
oocyst
wash
grade
seri
metal
siev
mesh
measur
remov
larg
debri
result
suspens
centrifug
min
g
pellet
resuspend
v
v
etherwat
centrifug
result
pellet
contain
oocyst
wash
three
time
water
treat
sodium
hypochlorit
min
three
wash
pellet
suspend
aqueou
potassium
dichrom
number
oocyst
count
hemacytomet
cell
thoma
pellet
store
week
use
calf
inocul
x
oocyst
c
parvum
suspend
ml
distil
water
halofuginon
lactat
use
deriv
febrifugin
compris
solut
mg
activ
substanc
per
millilit
requir
dose
anim
dilut
ml
water
drug
administ
oral
calv
milk
feed
calv
weigh
start
experi
day
infect
fecal
sampl
examin
presenc
rotaviru
coronaviru
e
coli
salmonella
experiment
infect
diseas
develop
drug
efficaci
assess
evalu
consist
fece
shed
oocyst
calf
growth
mortal
fresh
fecal
materi
collect
daili
pi
rectal
sampl
elimin
cryptosporidium
oocyst
detect
flotat
use
sheather
sucros
solut
oocyst
number
score
semiquantit
light
microscopi
magnif
scale
oocyst
less
one
oocyst
per
field
oocyst
oocyst
oocyst
result
analyz
analysi
varianc
fisher
test
comparison
mean
newmankeul
test
statist
signific
variabl
test
level
confid
anim
etiolog
agent
neonat
diarrhea
detect
tabl
coronavirus
detect
seven
anim
distribut
differ
experiment
group
elimin
rotavirus
fece
inocul
e
coli
establish
four
calv
one
anim
also
posit
salmonella
effect
halofuginon
lactat
weight
gain
oocyst
shed
summar
fig
infect
nonmed
calv
calv
medic
lowest
dosag
show
first
anorexia
follow
diarrhea
oocyst
shed
within
h
calv
exhibit
diarrhea
sever
day
two
group
two
surviv
calv
exhibit
profus
diarrhea
day
fecal
stain
vari
brown
orang
yellow
whitegrey
consist
vari
pasti
wateri
fece
contain
mucu
undigest
milk
sometim
string
blood
emiss
frequenc
increas
group
cryptosporidium
infect
greatli
impair
growth
calv
fig
pg
kg
day
medic
group
calv
exhibit
wateri
diarrhea
slightli
pasti
fece
observ
four
anim
day
day
medic
group
diarrhea
establish
group
weight
gain
appar
impair
medic
signific
differ
note
weight
gain
four
group
period
p
period
p
weight
gain
kg
day
medic
group
significantli
higher
two
group
kinet
c
parvum
oocyst
output
shown
fig
nonmed
calv
prepat
period
day
except
one
anim
shed
small
number
oocyst
surviv
calv
oocyst
shed
import
pi
decreas
stop
medic
group
slight
oocyst
shed
note
anim
halofuginon
lactat
administr
g
kgl
day
medic
group
oocyst
shed
observ
treatment
nevertheless
four
anim
start
shed
oocyst
immedi
drug
withdraw
particularli
high
oocyst
output
score
two
anim
medic
group
oocyst
shed
start
longer
drug
withdraw
four
calv
import
clinic
symptom
experiment
infect
associ
death
three
calv
control
group
clearli
demonstr
pathogen
c
parvum
presenc
neonat
enter
pathogen
calv
appar
interfer
result
result
clearli
demonstr
efficaci
halofuginon
lactat
medic
reduc
sever
clinic
cryptosporidiosi
calv
efficaci
drug
administ
pi
appear
clinic
symptom
dosedepend
dose
kg
abl
prevent
clinic
diseas
three
calv
five
die
result
infect
kg
dayt
clinic
symptom
observ
calf
medic
group
show
neg
weight
gain
weight
gain
first
experi
naciri
yvorr
dose
kg
day
close
associ
toxic
sideeffect
kgl
day
sign
toxic
observ
except
depress
weight
gain
medic
period
depress
weight
gain
first
day
life
may
ascrib
part
stress
suffer
anim
chang
rear
feed
condit
kg
dosag
allow
good
growth
comparison
unmed
kg
day
medic
group
period
day
weight
survivor
two
lastnam
group
increas
none
three
dose
ofhalofuginon
lactat
test
stop
oocyst
shed
complet
appar
oocyst
shed
delay
longer
higher
dose
drug
administ
kg
dayl
weak
develop
parasit
note
medic
afterward
kg
day
shed
occur
drug
withdraw
tg
kg
start
detriment
consequ
weight
gain
two
lastnam
group
villacorta
et
al
observ
similar
effect
treatment
natur
infect
calv
number
anim
restart
shed
also
close
link
dose
halofuginon
lactat
administ
author
argu
lower
dose
complet
prevent
develop
parasit
thu
facilit
develop
immun
prevent
reinfect
larger
dose
stop
cryptosporidia
life
cycl
complet
prevent
develop
immun
leav
anim
suscept
reinfect
practic
condit
possibl
calv
becom
reinfect
experi
anim
receiv
one
dose
c
parvum
oocyst
hous
separ
chanc
reinfect
limit
perhap
delay
oocyst
shed
reflect
pharmacodynam
mode
action
halofuginon
lactat
host
seem
indic
drug
cryptosporidiostat
inhibit
parasit
develop
coccidia
eg
eimeria
long
millard
observ
sporozoit
ofeimeria
tenella
eimeria
acervulina
develop
follow
drug
withdraw
even
treat
meticlorpindol
long
day
absenc
reinfect
previous
record
experiment
infect
lamb
show
profus
wateri
diarrhea
oocyst
shed
score
larg
dose
drug
mg
kg
day
day
immedi
stop
oocyst
shed
reinfect
follow
day
later
recurr
oocyst
shed
consequ
either
weight
gain
growth
naciri
yvorr
period
day
correspond
prepat
period
c
parvum
data
lamb
calv
might
indic
drug
may
destroy
schizogon
gamogon
stage
inhibit
sporozoit
restart
infect
drug
withdraw
avian
coccidiosi
shown
anticoccidi
drug
clinic
effect
eimeria
even
complet
stop
elimin
oocyst
unfortun
infect
recov
oocyst
test
conclus
medic
halofuginon
lactat
dose
dayl
period
consecut
day
prevent
mortal
induc
c
parvum
guarante
normal
weight
gain
moreov
guarante
secur
factor
five
